IP Verse

Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof

Patent No. EP3733847 (titled "Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof") was filed by Toolgen Incorporated on Oct 23, 2013. The application was issued on Jun 1, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
POHLMANMar 1, 2023HILGENDORF
SCHLICHMar 1, 2023SCHLICH
PATENT BOUTIQUESep 7, 2022PATENT BOUTIQUE
GRUNDJun 27, 2022GRUND
CRISPR THERAPEUTICSJun 2, 2022VOSSIUS & PARTNER
CRISPR THERAPEUTICSJun 2, 2022VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3733847

TOOLGEN INCORPORATED
Application Number
EP20164644A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
Apr 29, 2022
Publication Date
Jun 1, 2022
External Links
Slate, Register , Google Patents